Why Tenet Healthcare Stock Is Back in Focus After Q1 2026

Tenet Healthcare (THC) is back on investors’ radar after its first quarter 2026 report paired stronger profitability with raised full year earnings guidance and firmer confidence around revenue and EBITDA targets.

Recent trading has been choppy, with a 9.6% 7 day share price return contrasted by modestly negative moves over the past month and quarter. However, the 1 year total shareholder return of 30.24% and 3 year total shareholder return of 176.93% point to strong underlying momentum.

If Tenet’s recent earnings beat has you thinking more broadly about healthcare opportunities, it could be worth scanning other US-listed healthcare AI stocks through 35 healthcare AI stocks

With a value score of 6, an indicated intrinsic discount of about 61% and a share price that sits below the average analyst target, the key question is simple: is Tenet still undervalued or is the market already pricing in its future growth?

Most Popular Narrative: 19.3% Undervalued

Tenet Healthcare's most followed narrative pegs fair value at $240.60 a share versus the last close at $194.13. That puts the valuation front and center for anyone tracking the stock.

Tenet Healthcare is no longer just a hospital operator. It is evolving into a broader healthcare platform built around efficiency, integration, and long-term patient management. The growing importance of behavioral health strengthens that model rather than complicating it.

One key question is what kind of earnings profile supports that higher fair value. The narrative emphasizes margins, steady revenue expansion, and a profit mix that skews toward outpatient and specialized services. Readers may want to see how those inputs translate into the final number.

Result: Fair Value of $240.60 (UNDERVALUED)

However, this hinges on execution. Any squeeze on hospital margins or slower outpatient growth could challenge the idea that behavioral care can carry the story.

Next Steps

With sentiment clearly mixed, you have enough signals on both risk and reward to start forming your own view. It is therefore worth reviewing the 4 key rewards and 3 important warning signs

Looking for more investment ideas?

If you stop here, you might miss stocks that better fit your goals, so take a few minutes to scan fresh ideas tailored to different risk and income preferences.

• Target resilient compounders by checking companies in the 72 resilient stocks with low risk scores that may better align with a cautious, capital preservation mindset.
• Spot potential value opportunities by reviewing the 51 high quality undervalued stocks and see which stocks currently line up with strong fundamentals and pricing.
• Strengthen your core holdings by focusing on companies in the solid balance sheet and fundamentals stocks screener (44 results) that pair financial stability with solid underlying business profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.